AUS
NZ
UK
CA
USA
IND
UnitedHealth Group (NYSE: UNH), a prominent player in the healthcare and well-being sector, disclosed its first quarter 2024 earnings report on April 16, 2024. The company, listed on the New York Stock Exchange under the ticker symbol UNH, operates through two interrelated businesses: Optum and UnitedHealthcare. These entities collaborate to advance and refine the modern healthcare landscape.
Financial Performance Overview
In the initial quarter of 2024, UnitedHealth Group experienced robust revenue growth, with total revenue reaching a substantial US$99.8 billion. This marked an impressive increase of nearly US$8 billion compared to the corresponding period in the previous year. The company's earnings from operations for the quarter amounted to US$7.9 billion, inclusive of adverse effects amounting to US$872 million attributed to a cyberattack. Adjusted earnings from operations, which accounted for disruptions in the Change Healthcare segment and excluded direct response costs related to the cyberattack, stood at US$8.5 billion. The expansion in revenue and earnings was primarily fueled by an expanded customer base served by Optum and UnitedHealthcare.
Cash Flow and Shareholder Returns
Cash flows from operations in the first quarter of 2024 totaled US$1.1 billion. However, this figure was influenced by approximately US$3 billion due to the company's response to the cyberattack, including accelerated funding provided to healthcare providers. Moreover, the timing of receipts from the public sector also impacted cash flows. During the quarter, UnitedHealth Group returned US$4.8 billion to its shareholders through dividends and share repurchases.
Key Activities and Response to Cyberattack
UnitedHealth Group has been actively engaged in restoring the services affected by the cyberattack on Change Healthcare. Additionally, the company has extended significant financial assistance to healthcare providers impacted by the incident. To date, over US$6 billion in advance funding and interest-free loans have been provided to support affected healthcare providers. The total impact of the cyberattack in the first quarter amounted to US$0.74 per share. Looking ahead, the company anticipates impacts ranging from US$1.15 to US$1.35 per share for the full year 2024.
Furthermore, the company recorded a charge of approximately US$7 billion in the quarter related to the sale of its Brazil operations. This charge, primarily noncash, was attributed to cumulative foreign currency translation losses.
Outlook and Forecast
UnitedHealth Group revised its full-year 2024 net earnings outlook to a range of US$17.60 to US$18.20 per share, factoring in the impact of the Brazil sale and estimated direct response costs of the cyberattack. However, the company maintained its adjusted net earnings forecast at US$27.50 to US$28.00 per share. This adjusted earnings outlook excludes the effects of direct response costs and the Brazil sale but includes the estimated impact of business disruption amounting to US$0.30 to US$0.40 per share for the affected Change Healthcare services.
